RENU, TLON, ICNB & Today’s Extended Watchlist

Renuen Corp RENU

Our interest in RENU has been renewed. Yesterday, the stock was able to break resistance at the 50 & 100DMA’s as we had expressed hope for in our morning report, touching .004 at one point. Being as low as .0015 last week, gains on the order of 167% were possible.

As you can see on the chart below, the RSI has surpassed the 50-line and the 50DMA. The blue bars on the histogram flipped up to the bullish side, we can see a PPO crossover, and the Slow STO has passed through the 50MA overlay. All of this on increasing volume, leads us to a bullish opinion of RENU.

NEW YORK, NY and ST. CLOUD, FL–(Marketwire -07/26/12)- RenuEn Corporation (RENU), a rapidly expanding renewable energy roll-up company focused on solar, wind and geothermal energy solutions, today announced that the Company has signed a Letter of Intent to acquire Team Energy, Inc., a developer of renewable energy projects based in St. Cloud, Florida. >>FULL STORY


Talon Therapeutics, Inc. TLON

TLON enjoyed another nice day of gains on Wednesday, hitting a new 52-week high. We began mentioning it a couple of weeks back (July 11th), at which time the stock was trading as low as 1.28. Yesterday’s high of 1.72, marks a gain of 34%

Just a reminder, TLON has an upcoming FDA date on August 12th.


Iconic Brands, Inc. ICNB

We have our eye on ICNB as a momentum play. The stock was up considerably yesterday and Tuesday, with 700% in gains rolling in during that short time. We just want to keep it on the radar in case it keeps moving. The company released a corporate update yesterday, included here:

NEW YORK, Jul 25, 2012 (BUSINESS WIRE) — Iconic Brands, Inc. (Iconic) (OTCBB: ICNB) announces corporate updates as related to ongoing operations and forward looking plans. As previously announced in September of last year our wholly owned subsidiary, Iconic Imports Inc. was forced to file chapter 7 bankruptcy when a senior creditor foreclosed on the subsidiary assets. The bankruptcy hearing has been held without claim and is pending discharge. There is no effect on the capital structure; the company maintains approximately 52 million shares outstanding with approximately 20 million in the public float.

In the interim we have aggressively started the process to update our financials and engage in new business opportunities to create value for our shareholders. We anticipate having all of the financials updated by no later than the third quarter ending September 30th, 2012. We have put up a simple website to provide information while going through this process.


Today is the FDA PDUFA date for Horizon Pharma, Inc HZNP

The FDA will rule on HZNP’s RAYOS modified-release low dose prednisone. We have done considerably well with HZNP leading into today’s upcoming verdict, thus, it may be a good idea for us to take profits off of the table, in the event of no approval.


Extended Watchlist: